Springer Nature
Browse
13148_2019_742_MOESM9_ESM.pdf (364.62 kB)

MOESM9 of Epigenetic silencing of MEIS2 in prostate cancer recurrence

Download (364.62 kB)
journal contribution
posted on 2019-10-23, 08:27 authored by Maibritt Nørgaard, Christa Haldrup, Marianne Bjerre, Søren Høyer, Benedicte Ulhøi, Michael Borre, Karina Sørensen
Additional file 9: Figure S4. Association between DNA methylation of MEIS2 assay 1 and 2 and clinicopathological variables in the qMSP cohort. Clinicopathological variables examined: pathological Gleason score, pathological T-stage, surgical margin status, and CAPRA-S score (low: 0-2, intermediate: 3-5, high: ≥6). P-values were calculated using Mann-Whitney tests. Path., pathological. Surg., surgical. P, p-value.

Funding

Kræftens Bekæmpelse

History

Usage metrics

    Clinical Epigenetics

    Categories

    Keywords

    Prostate cancerDNA methylationRNA expressionMEIS2Epigenetic silencingBiomarkerPrognosis

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC